Ionis Pharmaceuticals (IONS) PT Raised to $106 at Barclays
Barclays analyst Eliana Merle raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $106.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
